CD274 and neoplasm: The first evidence came from the breakthrough preclinical study by Sivan et al. that highlighted the correlation of gut commensal populations of Bifidobacterium with delayed tumor growth and enhanced T cell tumor infiltration and anti-tumor immunity, supporting the efficacy of PD-L1 blockade [10].